TRANSPAN Webinar: Mechanisms of tumor heterogeneity and therapeutic vulnerabilities in PDAC

TRANSPAN Webinar: Mechanisms of tumor heterogeneity and therapeutic vulnerabilities in PDAC

We’re pleased to announce the launch of the TRANSPAN webinar series, aimed at sharing recent research and clinical developments, encouraging interdisciplinary collaboration, and supporting the training of early career researchers and clinicians. The webinars will take place monthly via Microsoft Teams,last one hour (30-45minutes of presentation and 15-30 minutes of discussion), and be recorded. Speakers—mainly TRANSPAN members—will offer both clinical and research-focused perspectives, with an emphasis on understanding PDAC in a clinical context and exploring translational advances. The first session will be on 22nd May. Certificates of attendance will be provided, and PhD students are especially encouraged to join, as the webinars can support their academic development and may count toward their university program records.

TOPIC: CLINICAL

Mechanisms of tumor heterogeneity and therapeutic vulnerabilities in PDAC

SPEAKER

  • Prof. Shiv K. Singh

     

    Mildred-Scheel Professor | Chair of Targeting
    Tumor Heterogeneity

    Dept. of Gastroenterology, GI Oncology, and Endocrinology

    University Medical Center Göttingen (UMG)
    Göttingen

LINK